What is Asmaa Chaudhry's NPI number?

Asmaa Chaudhry's National Provider Identifier (NPI) is 1366659351, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Asmaa Chaudhry's specialty?

Asmaa Chaudhry is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Asmaa Chaudhry located?

Asmaa Chaudhry's practice location on file with NPPES is 24560 Southpoint Drive, Suite 230, Aldie, VA 20105-3505.

What is Asmaa Chaudhry's phone number?

The practice phone number listed in the NPPES registry for Asmaa Chaudhry is (703) 957-0416.

Does Asmaa Chaudhry accept Medicare?

Asmaa Chaudhry is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Asmaa Chaudhry's NPI active?

Yes — Asmaa Chaudhry's NPI (1366659351) is active in the NPPES registry as of the last update on 2023-09-29.

IndividualActiveAccepts Medicare

Asmaa Chaudhry, MD

NPI 1366659351 · Dermatology Physician · Aldie, VA

Asmaa Chaudhry, MD is a Dermatology Physician provider in Aldie, VA (NPI 1366659351).

Provider details

NPI number: 1366659351
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 0101242155 (VA)

Practice location

24560 Southpoint Drive, Suite 230

Aldie, VA 20105-3505

Phone: (703) 957-0416

Fax: (703) 723-9752

Street-level locationGet directions

More VA providers

Mailing address

224d Cornwall St Nw Ste 403

Leesburg, VA 20176-2704

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101242155 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(70/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
595 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	152	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	141	$88
Destruction of Precancer Skin Growth, 1 Growth17000	77	$52
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	65	$125
Biopsy of Related Skin Growth, First Growth11102	51	$91
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	28	12
Triamcinolone Acetonide	27	23
Clobetasol Propionate	18	—
Fluocinonide	18	—
Mometasone Furoate	12	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$254 across 10 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-05-17
Last updated: 2023-09-29
Certified: 2023-09-29

Frequently asked questions

What is Asmaa Chaudhry's NPI number?: Asmaa Chaudhry's National Provider Identifier (NPI) is 1366659351, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Asmaa Chaudhry's specialty?: Asmaa Chaudhry is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Asmaa Chaudhry located?: Asmaa Chaudhry's practice location on file with NPPES is 24560 Southpoint Drive, Suite 230, Aldie, VA 20105-3505.
What is Asmaa Chaudhry's phone number?: The practice phone number listed in the NPPES registry for Asmaa Chaudhry is (703) 957-0416.
Does Asmaa Chaudhry accept Medicare?: Asmaa Chaudhry is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Asmaa Chaudhry's NPI active?: Yes — Asmaa Chaudhry's NPI (1366659351) is active in the NPPES registry as of the last update on 2023-09-29.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	152	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	141	$88
Destruction of Precancer Skin Growth, 1 Growth17000	77	$52
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	65	$125
Biopsy of Related Skin Growth, First Growth11102	51	$91
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	28	12
Triamcinolone Acetonide	27	23
Clobetasol Propionate	18	—
Fluocinonide	18	—
Mometasone Furoate	12	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$254 across 10 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments